Get started
OPTHEA LIMITEDOPTHEA LIMITEDOPTHEA LIMITED

OPTHEA LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

OPT chart


Full chart

OPT upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪738.77 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.440 AUD
Net income (FY)
‪−336.10 M‬ AUD
Revenue (FY)
‪190.25 K‬ AUD
Shares float
‪1.19 B‬
Beta (1Y)
3.82

About OPTHEA LIMITED


Sector
Health Technology
Industry
Biotechnology
CEO
Frédéric Guerard
Website
opthea.com
Headquarters
South Yarra
Founded
1984
ISIN
AU000000OPT2
FIGI
BBG000BMBF93
Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984, and is headquartered in South Yarra, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

OPT news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as OPT.

Frequently Asked Questions


The current price of OPT is 0.600 AUD — it has decreased by −0.83% in the past 24 hours. Watch OPTHEA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange OPTHEA LIMITED stocks are traded under the ticker OPT.
We've gathered analysts' opinions on OPTHEA LIMITED future price: according to them, OPT price has a max estimate of 2.69 AUD and a min estimate of 0.20 AUD. Watch OPT chart and read a more detailed OPTHEA LIMITED stock forecast: see what analysts think of OPTHEA LIMITED and suggest that you do with its stocks.
OPT reached its all-time high on Feb 24, 2000 with the price of 6.250 AUD, and its all-time low was 0.045 AUD and was reached on May 22, 1991. View more price dynamics on OPT chart.
See other stocks reaching their highest and lowest prices.
OPT stock is 3.36% volatile and has beta coefficient of 3.82. Track OPTHEA LIMITED stock price on the chart and check out the list of the most volatile stocks — is OPTHEA LIMITED there?
Today OPTHEA LIMITED has the market capitalization of ‪738.77 M‬, it has decreased by −13.57% over the last week.
Yes, you can track OPTHEA LIMITED financials in yearly and quarterly reports right on TradingView.
OPTHEA LIMITED is going to release the next earnings report on Aug 28, 2025. Keep track of upcoming events with our Earnings Calendar.
OPT earnings for the last half-year are −0.17 AUD per share, whereas the estimation was −0.22 AUD, resulting in a 20.66% surprise. The estimated earnings for the next half-year are −0.058 AUD per share. See more details about OPTHEA LIMITED earnings.
OPTHEA LIMITED revenue for the last half-year amounts to ‪240.84 K‬ AUD, despite the estimated figure of ‪115.46 K‬ AUD. In the next half-year revenue is expected to reach ‪143.30 K‬ AUD.
OPT net income for the last half-year is ‪−199.57 M‬ AUD, while the previous report showed ‪−188.49 M‬ AUD of net income which accounts for −5.87% change. Track more OPTHEA LIMITED financial stats to get the full picture.
No, OPT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OPT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OPTHEA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OPTHEA LIMITED technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OPTHEA LIMITED stock shows the strong sell signal. See more of OPTHEA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.